Emerging in the landscape of weight management therapy, retatrutide presents a distinct strategy. Unlike many current medications, retatrutide functions as a double agonist, simultaneously engaging both GLP peptide-1 (GLP-1) and glucose-sensitive insulinotropic substance (GIP) binding sites. The dual activation fosters multiple helpful effects, lik… Read More